MEASURES TO INCREASE USE OF SCREENING TESTS FOR POST-TRANSFUSION INFECTION

Mariko Kondo, M. Okamoto, Rieko Suzuki, M. Kurita, K. Horiba
{"title":"MEASURES TO INCREASE USE OF SCREENING TESTS FOR POST-TRANSFUSION INFECTION","authors":"Mariko Kondo, M. Okamoto, Rieko Suzuki, M. Kurita, K. Horiba","doi":"10.3925/JJTC1958.51.424","DOIUrl":null,"url":null,"abstract":"On July 30, 2003 the Revised Pharmaceutical Affairs Law and the Revised Transfusion Act were enacted by the Ministry of Health, Labor and Welfare to clarify the responsibilities of medical organizations. Taking this opportunity, the Hospital's Blood Transfusion Therapy Committee and Infection Control Committee undertook a review of methods of screening tests for post-transfusion infection. We decided to give patients a form letter to recommend they take a screening test for post-transfusion infection while providing notice to doctors that ‘2 months have passed since the transfusion (Blue Card)’. In addition, detailed discussions were held with respect to 1) test fees, 2) test criteria, 3) how to raise patients' awareness, and 4) how to enhance doctors' awareness. As a result, the use of screening tests for post-transfusion infection increased, from 6.8% to 54.6%, enabling us to confirm some effects. However, to fulfil our responsibilities to all patients receiving blood transfusion, the system for implementing this program requires urgent improvement. We thus aimed to further improve the system through operating the newly revised Blue Card system. In addition, it is necessary to create a system to ensure thorough implementation of the program with the electronic patient record due to commence in 2006.Meanwhile, the Ministry of Health, Labor and Welfare is expected to extend the application of patient assistance programs, in addition to implementing a system to ensure that patients receive safer blood transfusion.","PeriodicalId":86521,"journal":{"name":"Nihon Yuketsu Gakkai zasshi = Journal of the Japan Society of Blood Transfusion","volume":"51 1","pages":"424-429"},"PeriodicalIF":0.0000,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nihon Yuketsu Gakkai zasshi = Journal of the Japan Society of Blood Transfusion","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3925/JJTC1958.51.424","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

On July 30, 2003 the Revised Pharmaceutical Affairs Law and the Revised Transfusion Act were enacted by the Ministry of Health, Labor and Welfare to clarify the responsibilities of medical organizations. Taking this opportunity, the Hospital's Blood Transfusion Therapy Committee and Infection Control Committee undertook a review of methods of screening tests for post-transfusion infection. We decided to give patients a form letter to recommend they take a screening test for post-transfusion infection while providing notice to doctors that ‘2 months have passed since the transfusion (Blue Card)’. In addition, detailed discussions were held with respect to 1) test fees, 2) test criteria, 3) how to raise patients' awareness, and 4) how to enhance doctors' awareness. As a result, the use of screening tests for post-transfusion infection increased, from 6.8% to 54.6%, enabling us to confirm some effects. However, to fulfil our responsibilities to all patients receiving blood transfusion, the system for implementing this program requires urgent improvement. We thus aimed to further improve the system through operating the newly revised Blue Card system. In addition, it is necessary to create a system to ensure thorough implementation of the program with the electronic patient record due to commence in 2006.Meanwhile, the Ministry of Health, Labor and Welfare is expected to extend the application of patient assistance programs, in addition to implementing a system to ensure that patients receive safer blood transfusion.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
采取措施增加使用输血后感染筛查试验
2003年7月30日,厚生劳动省制定了《药事法修订案》和《输血法修订案》,明确了医疗机构的责任。借此机会,医院输血治疗委员会和感染控制委员会对输血后感染的筛查试验方法进行了审查。我们决定给患者发一封表格信,建议他们接受输血后感染筛查测试,同时向医生提供“输血已经过了2个月(蓝卡)”的通知。此外,还就1)检查费用,2)检查标准,3)如何提高患者的意识,4)如何提高医生的意识进行了详细的讨论。因此,输血后感染筛查试验的使用率从6.8%增加到54.6%,使我们能够确认一些效果。然而,为了履行我们对所有接受输血的患者的责任,实施这一计划的系统需要迫切改进。因此,我们打算通过实施新修订的蓝卡制度,进一步完善该制度。此外,从2006年开始,有必要建立一个系统,以确保彻底实施电子病历。另外,保健劳动福利部计划,在实施安全输血制度的同时,扩大患者支援制度的适用范围。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
THE EFFECT OF GLYCEROL-3-PHOSPHATE ON STORAGE OF CPD PRESERVED WHOLE BLOOD THE DISTRIBUTION OF HLA-A, B, C, Bf, C4 AND TWO LOCUS ASSOCIATION OF HEALTHY APHERESIS DONNOR IN YAMAGUCHI PREFECTURE, WESTERN AREA OF JAPAN RE-EXAMINATION OF BERNSTEIN'S CORRECTIONS TO THE MULTI-ALLELOMORPHISM IN THE ABO BLOOD GROUPS CLINICAL SIGNIFICANCE OF SERIAL EXAMINATION OF ANTI HUMAN IMMUNODEFICIENCY VIRUS ( HIV ) ANTIBODY AND HIV ANTIGEN IN HEMOPHILIACS WITH HIV INFECTION A NEW ADDITIVE SOLUTION CONTAINING PHOSPHOENOLPYRUVATE (PEP) FOR PLASMA AND LEUKOCYTE POOR RED CELL CONCENTRATES I. PEP for Red Cells Preservation as a Protein-Free-Medium
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1